Long-term exposure to PM

Air Pollutants / analysis Air Pollution / adverse effects COVID-19 Environmental Exposure / adverse effects Humans Particulate Matter / analysis SARS-CoV-2 Time Factors World Health Organization
COVID-19 COVID-19 mortality COVID-19 severity PM10

Journal

Environment international
ISSN: 1873-6750
Titre abrégé: Environ Int
Pays: Netherlands
ID NLM: 7807270

Informations de publication

Date de publication:
01 2022
Historique:
received: 09 09 2021
revised: 28 09 2021
accepted: 07 10 2021
pubmed: 23 10 2021
medline: 24 12 2021
entrez: 22 10 2021
Statut: ppublish

Résumé

Age, sex, race and comorbidities are insufficient to explain why some individuals remain asymptomatic after SARS-CoV-2 infection, while others die. In this sense, the increased risk caused by the long-term exposure to air pollution is being investigated to understand the high heterogeneity of the COVID-19 infection course. We aimed to assess the underlying effect of long-term exposure to NO A retrospective observational study was conducted with 2112 patients suffering COVID-19 infection. We built two sets of multivariate predictive models to assess the relationship between the long-term exposure to NO We found that the long-term exposure to PM These results demonstrate that long-term PM

Sections du résumé

BACKGROUND
Age, sex, race and comorbidities are insufficient to explain why some individuals remain asymptomatic after SARS-CoV-2 infection, while others die. In this sense, the increased risk caused by the long-term exposure to air pollution is being investigated to understand the high heterogeneity of the COVID-19 infection course.
OBJECTIVES
We aimed to assess the underlying effect of long-term exposure to NO
METHODS
A retrospective observational study was conducted with 2112 patients suffering COVID-19 infection. We built two sets of multivariate predictive models to assess the relationship between the long-term exposure to NO
RESULTS
We found that the long-term exposure to PM
DISCUSSION
These results demonstrate that long-term PM

Identifiants

DOI: 10.1016/j.envint.2021.106930 PMID: 34678637 PMC: PMC8519784
pubmed: 34678637
pii: S0160-4120(21)00555-9
doi: 10.1016/j.envint.2021.106930
pmc: PMC8519784
pii:
doi:

Substances chimiques

Air Pollutants 0
Particulate Matter 0

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

106930

Informations de copyright

Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Références

Immun Ageing. 2021 Jan 4;18(1):1
pubmed: 33390183
Environ Res. 2020 Aug;187:109650
pubmed: 32416357
Environ Res. 2020 Sep;188:109754
pubmed: 32526492
Sci Total Environ. 2020 Aug 1;728:138835
pubmed: 32334162
Adv Exp Med Biol. 2017;1017:59-102
pubmed: 29177959
Sci Total Environ. 2020 Nov 1;741:140396
pubmed: 32592974
BMC Pulm Med. 2021 Jan 6;21(1):12
pubmed: 33407347
Sci Rep. 2020 Feb 12;10(1):2402
pubmed: 32051443
Geogr Anal. 2021 Jul;53(3):397-421
pubmed: 32836331
Environ Res. 2021 Apr;195:110863
pubmed: 33609549
Environ Res. 2021 Apr;195:110723
pubmed: 33484722
Sci Rep. 2021 Feb 19;11(1):4263
pubmed: 33608563
Stat Med. 2011 Feb 20;30(4):377-99
pubmed: 21225900
JAMA. 2020 Apr 28;323(16):1574-1581
pubmed: 32250385
Sci Total Environ. 2020 Feb 10;703:135538
pubmed: 31759725
Eur Heart J Cardiovasc Pharmacother. 2022 Feb 16;8(2):157-164
pubmed: 33135047
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
J King Saud Univ Sci. 2021 May;33(3):101373
pubmed: 33867776
Int J Environ Res Public Health. 2021 May 11;18(10):
pubmed: 34064938
Environ Sci Pollut Res Int. 2021 May;28(17):22123-22130
pubmed: 33411285
J Med Virol. 2021 May;93(5):2938-2946
pubmed: 33470428
Mech Ageing Dev. 2021 Mar;194:111433
pubmed: 33444631
Environ Chem Lett. 2021;19(1):25-42
pubmed: 32982622
Cancer Lett. 2021 Jun 28;508:30-46
pubmed: 33757803
Environ Res. 2021 Apr;195:110898
pubmed: 33610583
J Infect. 2020 Aug;81(2):255-259
pubmed: 32447007
Epidemiology. 2014 May;25(3):368-78
pubmed: 24589872
Sci Rep. 2021 Feb 4;11(1):3088
pubmed: 33542313
Environ Res. 2022 Jan;203:111930
pubmed: 34425111
Infect Dis Poverty. 2021 Jan 4;10(1):3
pubmed: 33397470
Environ Res. 2021 Oct;201:111529
pubmed: 34147467
Int J Environ Res Public Health. 2020 Dec 11;17(24):
pubmed: 33322456
Environ Pollut. 2021 May 1;276:116682
pubmed: 33631687
Environ Res. 2021 Jan;192:110315
pubmed: 33058813
Environ Health Perspect. 2011 Sep;119(9):1266-71
pubmed: 21659039
J Travel Med. 2020 Sep 26;27(6):
pubmed: 32779721
J Infect Public Health. 2020 Dec;13(12):1833-1839
pubmed: 32788073
Int J Mol Sci. 2021 Feb 28;22(5):
pubmed: 33670865
Asia Pac J Clin Oncol. 2021 Jun;17(3):186-192
pubmed: 32970923
Environ Monit Assess. 2020 May 3;192(6):325
pubmed: 32363409
Toxicology. 2009 Jun 30;261(1-2):1-8
pubmed: 19379789
Int J Environ Res Public Health. 2021 Mar 22;18(6):
pubmed: 33809857
Environ Res. 2015 Feb;137:278-86
pubmed: 25601729
Environ Health Perspect. 2019 Jun;127(6):67004
pubmed: 31166133
Environ Res. 2020 Dec;191:110129
pubmed: 32853663
Acta Biomed. 2021 Feb 16;92(1):e2021166
pubmed: 33682802
Lancet Diabetes Endocrinol. 2021 Feb;9(2):82-93
pubmed: 33357491
Hum Genomics. 2021 Feb 3;15(1):10
pubmed: 33536081
Chemosphere. 2021 Mar;267:128903
pubmed: 33213879
Environ Health. 2013 May 28;12(1):43
pubmed: 23714370

Auteurs

Montse Marquès (M)

Universitat Rovira i Virgili, Laboratory of Toxicology and Environmental Health, School of Medicine, IISPV, Sant Llorenç 21, 43201 Reus, Catalonia, Spain. Electronic address: montserrat.marques@urv.cat.

Eudald Correig (E)

Universitat Rovira i Virgili, Department of Biostatistics, Sant Llorenç 21, 43201 Reus, Catalonia, Spain.

Daiana Ibarretxe (D)

Universitat Rovira i Virgili, LIPIDCAS, University Hospital Sant Joan IISPV, CIBERDEM, Reus, Spain.

Eva Anoro (E)

LIPIDCAS, Pius Hospital Valls, Valls, Spain.

Juan Antonio Arroyo (J)

Lipid Unit, University Hospital Santa Creu i Sant Pau, Barcelona Autonomous University, Barcelona, Spain.

Carlos Jericó (C)

Lipid Unit, Hospital Moises Broggi. Consorci Sanitari Integral. Sant Joan Despí, Spain.

Rosa M Borrallo (RM)

Internal Medicine Department. Terrasa Hospital. Consorci Sanitari Terrassa, Spain.

Marcel la Miret (M)

LIPIDCAS, Endocrinology Department, Hospital Verge de la Cinta, Tortosa, Spain.

Silvia Näf (S)

LIPIDCAS, Endocrinology Department, University Hospital Joan XXIII, IISPV. CIBERDEM. Universitat Rovira i Virgili. Tarragona, Spain.

Anna Pardo (A)

Internal Medicine Department, Hospital Delfos, Barcelona, Spain.

Verónica Perea (V)

Lipid Unit, Hospital Mutua Terrasa, Barcelona, Spain.

Rosa Pérez-Bernalte (R)

LIPIDCAS, Hospital del Vendrell, El Vendrell, Spain.

Rafael Ramírez-Montesinos (R)

LIPIDCAS, Hospital Sant Pau i Santa Tecla, Tarragona, Spain.

Meritxell Royuela (M)

Lipid Unit, ALTHAIA, Xarxa Assistencial Universitària de Manresa, Spain.

Cristina Soler (C)

Lipid Unit, Hospital Santa Caterina, Girona, Spain.

Maria Urquizu-Padilla (M)

Lipid Unit, University Hospital Vall d'Hebron, Barcelona Autonomous University, Barcelona, Spain.

Alberto Zamora (A)

Lipid Unit, Corporació de Salut del Maresme i la Selva, Hospital de Blanes, Spain.

Juan Pedro-Botet (J)

Lipid Unit, University Hospital del Mar, Barcelona Autonomous University, Barcelona, Spain.

Lluís Masana (L)

Universitat Rovira i Virgili, LIPIDCAS, University Hospital Sant Joan IISPV, CIBERDEM, Reus, Spain.

José L Domingo (JL)

Universitat Rovira i Virgili, Laboratory of Toxicology and Environmental Health, School of Medicine, IISPV, Sant Llorenç 21, 43201 Reus, Catalonia, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Actions chimiques et utilisations › Actions toxiques › Polluants environnementaux › Polluants atmosphériques › Long-term exposure to PM
questionsmedicales.fr › Environnement et santé publique › Santé publique › Pollution de l'environnement › Pollution de l'air › Long-term exposure to PM
questionsmedicales.fr › Maladies de l'appareil respiratoire › Infections de l'appareil respiratoire › Pneumopathie infectieuse › Pneumopathie virale › COVID-19 › Long-term exposure to PM
questionsmedicales.fr › Environnement et santé publique › Santé publique › Pollution de l'environnement › Exposition environnementale › Long-term exposure to PM
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Long-term exposure to PM
questionsmedicales.fr › Mélanges complexes › Matière particulaire › Long-term exposure to PM
questionsmedicales.fr › Virus › Virus à ARN › Virus à ARN à brin positif › Nidovirales › Coronaviridae › Coronavirus › Betacoronavirus › Virus du SRAS › SARS-CoV-2 › Long-term exposure to PM
questionsmedicales.fr › Phénomènes physiques › Temps › Facteurs temps › Long-term exposure to PM
questionsmedicales.fr › Organisations et économie des soins de santé › Organismes › Agences internationales › Nations Unies › Organisation mondiale de la santé › Long-term exposure to PM